AstraZeneca on Wednesday convinced a federal judge in Delaware to throw out a jury’s decision that the company owes $107.5 million for infringing cancer-drug patents belonging to Pfizer subsidiary Wyeth. U.S. District Judge Matthew Kennelly determined that the two patents Pfizer accused AstraZeneca of infringing with its blockbuster lung-cancer drug Tagrisso were invalid. Spokespeople for